OMDA Omada Health, Inc.

Fundamentals / CIK 0001611115 / USD

Omada Health, Inc. reported $333.0M in revenue and net income of $14.03M for the trailing twelve months ended September 30, 2026 (up 34.2% year over year), with a 70.7% gross margin and a 2.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OMDA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$263.6M$131.8M$0-$85.24MFY 2023 Revenue: $122.8MFY 2023 Net Income: -$67.51M2023FY 2024 Revenue: $169.8MFY 2024 Net Income: -$47.14M2024FY 2025 Revenue: $260.2MFY 2025 Net Income: -$12.78M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $260.2M $169.8M $122.8M
Cost of Revenue $89.27M $66.92M $52.81M
Gross Profit $170.9M $102.9M $69.97M
Research & Development $40.68M $35.92M $33.74M
Selling, General & Admin $142.2M $110.6M $102.2M
Total Operating Expenses $182.9M $146.5M $136.0M
Operating Income -$11.97M -$43.65M -$66.00M
EBITDA -$6.48M -$38.85M -$61.55M
Interest Income $5.30M $805K $5.78M
Interest Expense $2.53M $4.51M $4.71M
Income Before Tax -$12.78M -$47.14M -$67.51M
Income Tax Expense $0 $0 $0
Net Income -$12.78M -$47.14M -$67.51M
Basic EPS -$0.35 -$6.11 -$9.52
Diluted EPS -$0.35 -$6.11 -$9.52
Basic Shares Outstanding 36.6M 7.7M 7.1M
Diluted Shares Outstanding 36.6M 7.7M 7.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $91.31M $87.83M $78.05M $75.85M $68.03M $61.37M $54.96M --
Cost of Revenue $22.02M $24.05M $29.36M $22.18M $22.96M $21.07M $23.06M --
Gross Profit $69.28M $63.79M $48.69M $53.66M $45.07M $40.31M $31.90M --
Research & Development $15.27M $14.62M $12.70M $11.55M $10.30M $10.02M $8.81M --
Selling, General & Admin $49.19M $45.61M $40.78M $38.83M $37.28M $34.63M $31.49M --
Total Operating Expenses $64.46M $60.24M $53.47M $50.38M $47.58M $44.65M $40.30M --
Operating Income $4.82M $3.55M -$4.78M $3.28M -$2.51M -$4.34M -$8.40M --
EBITDA $6.50M $5.13M -$3.27M $4.73M -$1.15M -$2.99M -$7.06M --
Interest Income $1.99M $1.76M $1.83M $1.89M $2.01M $863K $542K --
Interest Expense $262K $14K $18K $13K $353K $1.09M $1.07M --
Income Before Tax $6.55M $5.29M -$2.97M $5.16M -$3.18M -$5.31M -$9.45M --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 --
Net Income $6.55M $5.29M -$2.97M $5.16M -$3.18M -$5.31M -$9.45M -$8.25M
Basic EPS $0.11 $0.09 -$0.05 -- -$0.06 -$0.24 -$1.15 --
Diluted EPS $0.10 $0.08 -$0.05 -- -$0.06 -$0.24 -$1.15 --
Basic Shares Outstanding 61.5M 59.7M 58.9M -- 57.7M 22.0M 8.2M --
Diluted Shares Outstanding 67.1M 63.9M 58.9M -- 57.7M 22.0M 8.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $222.0M $76.39M
Cash & Short-Term Investments $222.0M $76.39M
Accounts Receivable, Net $34.59M $23.42M
Inventory $4.49M $3.30M
Other Current Assets $1.89M $2.14M
Total Current Assets $272.9M $113.1M
Property, Plant & Equipment, Net $7.94M $5.62M
Goodwill $13.24M $13.24M
Intangible Assets $2.41M $4.26M
Other Non-Current Assets $165K $5.04M
Total Non-Current Assets $32.47M $37.83M
Total Assets $305.4M $150.9M
Accounts Payable $10.28M $4.17M
Deferred Revenue (Current) $25.06M $19.53M
Total Current Liabilities $75.73M $53.95M
Long-Term Debt $0 $29.77M
Other Non-Current Liabilities $0 $285K
Total Non-Current Liabilities $0 $32.31M
Total Liabilities $75.73M $86.26M
Total Debt (incl. Leases) $0 $30.19M
Common Stock $58K $8.0K
Retained Earnings -$456.7M -$444.0M
Total Stockholders' Equity $229.7M -$384.4M
Total Equity $229.7M -$384.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2024-12-31
Cash & Cash Equivalents $243.2M $221.7M $211.8M $222.0M $198.6M $223.1M $76.39M
Cash & Short-Term Investments $243.2M $221.7M $211.8M $222.0M $198.6M $223.1M $76.39M
Accounts Receivable, Net $48.19M $56.57M $39.98M $34.59M $41.45M $33.29M $23.42M
Inventory $4.88M $4.12M $3.83M $4.49M $3.15M $3.47M $3.30M
Other Current Assets -- -- -- $1.89M -- -- $2.14M
Total Current Assets $315.1M $294.9M $269.4M $272.9M $254.9M $271.1M $113.1M
Property, Plant & Equipment, Net $9.74M $9.10M $8.46M $7.94M $7.54M $6.48M $5.62M
Goodwill $13.24M $13.24M $13.24M $13.24M $13.24M $13.24M $13.24M
Intangible Assets $1.10M $1.54M $1.98M $2.41M $2.85M $3.29M $4.26M
Other Non-Current Assets $417K $215K $226K $165K $199K $234K $5.04M
Total Non-Current Assets $33.48M $33.31M $33.37M $32.47M $32.57M $31.87M $37.83M
Total Assets $348.5M $328.2M $302.8M $305.4M $287.5M $303.0M $150.9M
Accounts Payable $8.38M $11.80M $8.10M $10.28M $5.34M $7.40M $4.17M
Deferred Revenue (Current) $25.84M $27.70M $29.35M $25.06M $27.16M $25.52M $19.53M
Total Current Liabilities $75.38M $75.48M $68.68M $75.73M $70.12M $57.99M $53.95M
Long-Term Debt -- -- -- $0 $0 $29.97M $29.77M
Other Non-Current Liabilities $0 $0 $0 $0 $0 $373K $285K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $30.77M $32.31M
Total Liabilities $75.38M $75.48M $68.68M $75.73M $70.12M $88.76M $86.26M
Total Debt (incl. Leases) -- -- -- $0 $0 $29.97M $30.19M
Common Stock $62K $61K $59K $58K $58K $56K $8.0K
Retained Earnings -$447.9M -$454.4M -$459.7M -$456.7M -$461.9M -$458.7M -$444.0M
Total Stockholders' Equity $273.2M $252.7M $234.1M $229.7M $217.3M $214.2M -$384.4M
Total Equity $273.2M $252.7M $234.1M $229.7M $217.3M $214.2M -$384.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$12.78M -$47.14M -$67.51M
Depreciation & Amortization $5.49M $4.80M $4.45M
Stock-Based Compensation $12.96M $9.42M $8.74M
Change in Receivables -$12.36M -$8.80M -$5.34M
Change in Inventory -$1.19M $318K -$74K
Change in Payables $6.29M $399K -$286K
Operating Cash Flow $18.25M -$34.18M -$49.74M
Capital Expenditure -$1.32M -$596K -$416K
Free Cash Flow $16.93M -$34.77M -$50.15M
Investing Cash Flow -$5.83M -$3.86M -$2.92M
Financing Cash Flow $133.2M -$1.21M $179K
Net Change in Cash $145.6M -$39.25M -$52.48M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $6.55M $5.29M -$2.97M $5.16M -$3.18M -$5.31M -$9.45M -$8.25M
Depreciation & Amortization $1.68M $1.58M $1.51M $1.45M $1.36M $1.35M $1.33M --
Stock-Based Compensation $5.85M $5.63M $4.21M $3.75M $3.54M $2.83M $2.84M --
Change in Receivables $7.25M -$16.97M -$6.21M $7.16M -$9.15M -$3.86M -$6.50M --
Change in Inventory -$761K -$288K $655K -$1.34M $321K -$427K $254K --
Change in Payables -$3.61M $3.65M -$2.12M $4.92M $357K $733K $283K --
Operating Cash Flow $15.14M $4.01M -$11.83M $21.38M $10.13M $2.86M -$16.12M --
Capital Expenditure -$118K -$146K -$78K -$199K -$537K -$271K -$315K --
Free Cash Flow $15.02M $3.86M -$11.91M $21.18M $9.60M $2.59M -$16.43M --
Investing Cash Flow -$1.63M -$1.66M -$1.56M -$1.35M -$1.99M -$1.25M -$1.25M --
Financing Cash Flow $7.93M $7.60M $3.12M $3.38M -$32.66M $162.1M $372K --
Net Change in Cash $21.44M $9.95M -$10.27M $23.41M -$24.52M $163.7M -$17.00M --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Gross Margin 65.7% 60.6% 57.0%
Operating Margin -4.6% -25.7% -53.8%
Net Profit Margin -4.9% -27.8% -55.0%
Return on Equity (ROE) -5.6% -- --
Return on Assets (ROA) -4.2% -31.2% --
Current Ratio 3.60x 2.10x --
Quick Ratio 3.54x 2.03x --
Debt to Equity 0.00x -- --
Revenue Growth (YoY) +53.2% +38.3% --
Gross Profit Growth (YoY) +66.2% +47.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 70.7% 68.2% 66.3% 65.7% -- -- -- --
Operating Margin 2.1% -0.1% -2.9% -4.6% -- -- -- --
Net Profit Margin 4.2% 1.4% -2.2% -4.9% -- -- -- --
Return on Equity (ROE) 5.1% 1.7% -2.7% -5.6% -12.0% -15.0% -- --
Return on Assets (ROA) 4.0% 1.3% -2.1% -4.2% -9.1% -10.6% -- -31.2%
Current Ratio 4.18x 3.91x 3.92x 3.60x 3.64x 4.68x -- 2.10x
Quick Ratio 4.11x 3.85x 3.87x 3.54x 3.59x 4.62x -- 2.03x
Debt to Equity -- -- -- 0.00x 0.00x 0.14x -- --
Revenue Growth (YoY) +34.2% +43.1% +42.0% -- +49.5% +48.9% -- --
Gross Profit Growth (YoY) +53.7% +58.3% +52.6% -- +57.8% +62.3% -- --
Operating Cash Flow Growth (YoY) +49.4% +40.2% -- -- -- -- -- --
Free Cash Flow Growth (YoY) +56.5% +49.2% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001611115) · from December 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal